FuturHealth vs Hims
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
FuturHealth
Best for pending product verificationStarting at $199/mo
Hims
Best for mainstream telehealth GLP-1 accessStarting at $199/mo
Side-by-Side Comparison
| Feature | FuturHealth | Hims |
|---|---|---|
| Overall Score | 7.1/10 | ✓7.4/10 |
| Starting Price | $199/mo | $199/mo |
| Editorial Rating | 3.6 ★ /5 | ✓3.7 ★ /5 |
| Features | 2 features | 2 features |
| States Available | 0 | ✓50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
FuturHealth
Pros
- ✓Katalys-approved program at $180 default CPA — non-trivial commission
- ✓Explicitly positioned around weight loss medication (not a general telehealth catch-all)
Cons
- ✗Stub entry — exact drug formulary, pricing tiers, states served, and pharmacy partners need a YMYL verification pass
- ✗Confidence is LOW until that pass is done
- ✗Domain not yet verified — futurhealth.com may not be the correct landing page
Hims
Pros
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Our Verdict
Hims edges out FuturHealth with a higher overall score of 7.4/10 and is particularly strong for mainstream telehealth GLP-1 access. FuturHealth remains a solid alternative, especially if you're looking for pending product verification.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.